IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
- PMID: 17675517
- DOI: 10.4049/jimmunol.179.4.2551
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
Abstract
IL-33 (IL-1F11) is a recently described member of the IL-1 family of cytokines that stimulates the generation of cells, cytokines, and Igs characteristic of a type 2 immune response. IL-33 mediates signal transduction through ST2, a receptor expressed on Th2 and mast cells. In this study, we demonstrate that IL-33 and ST2 form a complex with IL-1R accessory protein (IL-1RAcP), a signaling receptor subunit that is also a member of the IL-1R complex. Additionally, IL-1RAcP is required for IL-33-induced in vivo effects, and IL-33-mediated signal transduction can be inhibited by dominant-negative IL-1RAcP. The implications of this shared usage of IL-1RAcP by IL-1(alpha and beta) and IL-33 are discussed.
Similar articles
-
The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.Immunol Res. 2013 May;56(1):122-30. doi: 10.1007/s12026-013-8388-9. Immunol Res. 2013. PMID: 23435764
-
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.Cytokine. 2007 Dec;40(3):216-25. doi: 10.1016/j.cyto.2007.09.013. Epub 2007 Nov 19. Cytokine. 2007. PMID: 18023358
-
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.Immunity. 2005 Nov;23(5):479-90. doi: 10.1016/j.immuni.2005.09.015. Immunity. 2005. PMID: 16286016
-
The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.Mol Immunol. 2015 Jan;63(1):80-5. doi: 10.1016/j.molimm.2014.06.018. Epub 2014 Jul 10. Mol Immunol. 2015. PMID: 25017307 Review.
-
IL-1, IL-18, and IL-33 families of cytokines.Immunol Rev. 2008 Jun;223:20-38. doi: 10.1111/j.1600-065X.2008.00624.x. Immunol Rev. 2008. PMID: 18613828 Review.
Cited by
-
Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases.J Neuroimmune Pharmacol. 2013 Jun;8(3):643-50. doi: 10.1007/s11481-013-9439-7. Epub 2013 Feb 10. J Neuroimmune Pharmacol. 2013. PMID: 23397250 Free PMC article.
-
IL-33 activates tumor stroma to promote intestinal polyposis.Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2487-96. doi: 10.1073/pnas.1422445112. Epub 2015 Apr 27. Proc Natl Acad Sci U S A. 2015. PMID: 25918379 Free PMC article.
-
Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected Kinases.Cells. 2023 Nov 24;12(23):2700. doi: 10.3390/cells12232700. Cells. 2023. PMID: 38067128 Free PMC article.
-
Osthole attenuates ovalbumin‑induced lung inflammation via the inhibition of IL‑33/ST2 signaling in asthmatic mice.Int J Mol Med. 2020 Oct;46(4):1389-1398. doi: 10.3892/ijmm.2020.4682. Epub 2020 Jul 22. Int J Mol Med. 2020. PMID: 32700747 Free PMC article.
-
IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung.Nanotoxicology. 2013 Sep;7(6):1070-81. doi: 10.3109/17435390.2012.702230. Epub 2012 Jun 29. Nanotoxicology. 2013. PMID: 22686327 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases